Title : High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment.

Pub. Date : 2015 Nov 2

PMID : 26525741






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 High SLFN11 expression predicts better survival for patients with KRAS exon 2 wild type colorectal cancer after treated with adjuvant oxaliplatin-based treatment. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens
2 CONCLUSIONS: SLFN11 expression predicts good better survival in colorectal cancer patients with KRAS exon 2 wild type who have received oxaliplatin based adjuvant chemotherapy. Oxaliplatin KRAS proto-oncogene, GTPase Homo sapiens